Rechercher dans ce blog

Friday, October 14, 2022

Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial | Leukemia - Nature.com

[unable to retrieve full-text content]

Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial | Leukemia  Nature.com
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial | Leukemia - Nature.com
Read More
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Dear Lina, – The Brooklyn Rail - Brooklyn Rail

Goethe’s “To Lina” commands that the letters of the page, black on white, be not read but breathed so that our hearts “now can break.” What...